Exercise, cancer and cardiovascular disease: what should clinicians advise?
Year: 2020
Type: review
Abstract: Cardiovascular disease is one of the leading causes of morbidity and mortality in persons with cancer. The elevated risk is thought to derive from the combination of cardiovascular risk factors and direct cardiotoxicity from cancer therapies. Exercise may be a potential strategy to counteract these toxicities and maintain cardiovascular reserve. In this article, we review the evidence for the potential cardioprotective effects of exercise training in cancer patients before, during, and following treatment. We also propose a patient-tailored approach for the development of targeted prescriptions based on individual exercise capacity and cardiovascular reserve.
Authors: Allison Zimmerman, Maria Isabel Camara Planek, Catherine Chu, Opeyemi Oyenusi, Agne Paner, Kerryn Reding, Jamario Skeete, Brian Clark, Tochi M. Okwuosa
Institutions: Rush University Medical Center, Fred Hutch Cancer Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3083508594